FDA Adverse Event Malfunction Summary report: N

ORSIRO MISSION US 3.5/22

MDR report key: 24019209 · Received January 9, 2026

Report

Report Number
8043892-2025-12182
Event Type
Malfunction
Date Received
January 9, 2026
Date of Event
December 17, 2025
Report Date
January 9, 2026
Manufacturer
BIOTRONIK AG
Product Code
NIQ
UDI-DI
07640130456099
PMA / PMN Number
P170030
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

COMBINATION PRODUCT: YES. NEITHER THE AFFECTED DEVICE NOR THE ANGIOGRAPHIC MATERIAL WAS RETURNED. THEREFORE, NO TECHNICAL INVESTIGATION ON THE SUBJECT COULD BE PERFORMED. THE PRODUCTION DOCUMENTATION WAS REVIEWED TO ESTABLISH WHETHER A DEVIATION FROM THE MANUFACTURING PROCESS COULD BE THE CAUSE FOR THE REPORTED EVENT. REVIEW OF THE PRODUCTION DOCUMENTATION CONFIRMED THAT THE DEVICE WAS MANUFACTURED ACCORDING TO SPECIFICATIONS AND PASSED ALL IN-PROCESS AND FINAL INSPECTIONS. BASED ON THE CONDUCTED INVESTIGATIONS, NO MATERIAL OR MANUFACTURING RELATED ROOT CAUSE COULD BE DETERMINED.

Description of Event or Problem · 0

THE ORSIRO MISSION DRUG-ELUTING STENT SYSTEM WAS SELECTED FOR TREATMENT OF A MODERATELY CALCIFIED LESION (89 % STENOSIS DEGREE) IN A SEVERELY TORTUOUS SEGMENT OF THE DISTAL RCA. PRE-DILATION OF THE LESION WAS PER-FORMED. THE AFFECTED DEVICE WAS INTRODUCED INTO THE PATIENT'S BODY BUT COULD NOT CROSS THE LESION. THE PHYSICIAN WAS ABLE TO CROSS THE LESION USING ANOTHER MANUFACTURERS STENT. THE COMPLAINT DEVICE WAS DISCARDED AT THE HOSPITAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
78561 ORSIRO MISSION US 3.5/22 CORONARY DRUG-ELUTING STENT NIQ BIOTRONIK AG 453953 04253775 07640130456099

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown